Hypoport SE Reports Strong Start in 2024 with Double-Digit Growth

Hypoport SE announced a strong financial performance for the first quarter of 2024, with a significant increase in revenue and EBIT. Consolidated revenue grew by 15% year-over-year, totaling €107 million. This was primarily driven by robust results from the mortgage finance business models within the Real Estate & Mortgage Platforms segment, which saw a 24% increase in revenue. The group's EBIT also saw a substantial rise, more than quadrupling to €4.3 million.

The improved performance in the mortgage finance sector was attributed to increased transaction volumes across various platforms such as Europace, Finmas, and Genopace, and heightened sales activity from Dr. Klein. The positive trend was supported by lower long-term interest rates and declining property prices, which have made home purchasing more attractive compared to renting.

Although the Financing Platforms segment struggled with a slight decrease in revenue, down 6% to €17 million, the Insurance Platforms segment managed to grow by 5%, reaching €18 million. This growth was largely supported by successful client acquisitions in the previous year for the occupational insurance subsegment centered around the ePension platform.

Hypoport's CEO, Ronald Slabke, commented on the positive results as a testament to the strategic measures implemented in the past 18 months, which have significantly enhanced market presence, particularly in the mortgage finance market undergoing current upheavals.